Details About Generic Salt ::  Hetastar

Main Medicine Class:: Plasma expander   

(HET-uh-starch)
Hespan
Class: Plasma expander

 

Drugs Class ::

 Action Produces expansion of plasma volume. Does not have oxygen-carrying capacity or contain plasma protein, so it is not blood or plasma substitute.

Indications for Drugs ::

 Indications Adjunct therapy for plasma volume expansion in shock due to hemorrhage, burns, surgery, sepsis, or other trauma; adjunct in leukapheresis to improve harvesting and increase yield of granulocytes.

Drug Dose ::

 Route/Dosage

Plasma Volume Expansion

ADULTS: IV 500 to 1000 ml/day; dosage does not usually exceed 1500 ml/day.

Leukapheresis

ADULTS: IV 250 to 700 ml.

Contraindication ::

 Contraindications Severe bleeding disorders; severe cardiac failure; renal failure with oliguria or anuria.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: No data available. Special risk patients: Due to possibility of circulatory overload, take special care when administering to patients with renal impairment, at risk of pulmonary edema, or with CHF. Hypersensitivity: May cause anaphylactoid reactions.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CNS: Headache. DERM: Itching. EENT: Submaxillary and parotid glandular enlargement. GI: Vomiting. OTHER: Anaphylactoid reactions (eg, periorbital edema, urticaria, wheezing, mild temperature elevation); chills; mild influenza-like symptoms; muscle pain; peripheral edema of lower extremities.

Drug Mode of Action ::  

 Action Produces expansion of plasma volume. Does not have oxygen-carrying capacity or contain plasma protein, so it is not blood or plasma substitute.

Drug Interactions ::

 Interactions None well documented.

Drug Assesment ::

 Assessment/Interventions

  • Obtain complete history, including drug history and any known allergies.
  • Assess for bleeding disorders and severe cardiac failure with oliguria or anuria.
  • Take baseline vital signs and hematologic parameters before administration of drug.
  • Check vital signs q 5 min for first 30 min following administration.
  • Monitor urinary output. If output does not increase, report to health care provider.
  • Monitor CVP during infusion to assess for circulatory overload (elevated CVP, rales/crackles, shortness of breath during and after administration).
  • Report prolonged PT, PTT, bleeding and clotting times, decreased Hct, decreased plasma proteins to health care provider.
  • Report anaphylactoid reactions (eg, periorbital edema, urticaria, wheezing, fever), chills, muscle pain, peripheral edema to health care provider.
  • During leukapheresis, monitor CBC, differential WBC count, Hgb, Hct, PT, and PTT.

Drug Storage/Management ::

 Administration/Storage

  • Administer by IV infusion only.
  • Store at room temperature.
  • Do not use if solution is turbid deep brown or if crystalline precipitate forms.

Drug Notes ::

 Patient/Family Education

  • Instruct patient to report these symptoms to health care provider: Itching, dyspnea, chills, myalgia, headache, vomiting and glandular enlargement.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.